Read Larry Connors' blog – Short Term Trading Strategies
Sign-up for our FREE Stock Alerts at http://www.otcstockexchange.com !
OpenCell BioMed Inc. (OTCBB: OCBM - http://finance.yahoo.com/q?s=ocbm.ob ) (Thu, Nov 6, 2008, 8:30 am ET) OpenCell BioMed Inc. is a medical device designer and manufacturer specializing in innovative designs merging proprietary biomedical materials with human cell biology. The company is developing a unique line of dental implants and related products for sale worldwide. OpenCell BioMed is differentiated by its proprietary paradigm shift surface coating/material TI- FOAM(TM) used as the bone to implant interface enabling dental implant systems greater short and long term stability with a minimally invasive techniques compared to traditional dental implant systems. In 2006, the global dental implant market was valued at over $1,790 million (www.mrg.net). Studies show that 69% of adults ages 35 to 44 have lost at least one permanent tooth to an accident, gum disease, a failed root canal or tooth decay. Furthermore, by age 74, 26% of adults have lost all of their permanent teeth and with the number of Americans over 55 growing by 60% in the next 20 years and their buying power exceeding $2 trillion by 2007. (Business Communications Co., Inc., February 2005)
"We are excited to be entering the multi-billion dollar a year medical device market. We are confident that OpenCell BioMed will be able to capture a significant market share in a sector that is seeing an erosion of market share from previously dominant players. With the aging population and with a doubling in the last decade of healthcare spending OpenCell BioMed and its proprietary products are uniquely positioned for many years of unprecedented growth." (Dr. Mislav Pavelic CEO-OpenCell BioMed Inc.)
About OpenCell BioMed Inc.
OpenCell BioMed is a medical device designer and manufacturer specializing in innovative designs merging proprietary biomedical materials with human cell biology. The company is developing a unique line of dental implants and related products for sale worldwide.
About Dental Implants
Dental implants are designed as permanent replacements for missing teeth. A dental implant is a metal post that is surgically placed into the bone under the gums. The purpose of the placement into the bone is to encourage the integration of the dental implants. The bone actually grows around the dental implant, making the tooth secure. A replacement tooth is attached to the titanium post by means of a final abutment. Did you know that dental implants are frequently the best treatment option for replacing missing teeth? Rather than resting on the gum line like removable dentures, or using adjacent teeth as anchors like fixed bridges, dental implants are long-term replacements.
Zynex, Inc. (OTCBB: ZYXI - http://finance.yahoo.com/q?s=zyxi.ob ) (Thu, Nov 6, 2008, 9:20 am ET) Zynex, Inc., a provider of pain management systems and electrotherapy products for medical patients with functional disability, announces an increase in its orders of 136% for October of 2008 compared to the same month last year.
Thomas Sandgaard, CEO, said: "We are excited to see our orders continue to increase and post another record month. We also are continuing our discussions with Anthem with the goal of a better result than the previously announced claim. We continue to have a good relationship with Anthem and provide service to patients with Anthem insurance."
Zynex received 3,177 orders for October of 2008; of this number, 264 were orders for devices for which Anthem is currently denying payments. Although the Company is moving to only providing Anthem insureds with alternative and currently reimbursed devices, some orders were still in the pipeline and included in the orders for October 2008. In addition, the Company is seeking to replace some unreimbursed devices placed in October with Anthem patients.
Zynex received 2,643 orders in September of 2008; of these, 624 orders were for devices for which Anthem is currently denying payments and which could have been replaced with alternative devices in Zynex's portfolio. Orders in October of 2007 were 1,452 of which 217 were for devices that Anthem is currently denying payment.
Zynex has not yet finalized its results for the third and fourth quarters of 2008, including the impact of increased orders.
Ronn Motor Company (Pink Sheets: RNNM - http://finance.yahoo.com/q?s=RNNM.PK ) (Fri, Nov 7, 2008, 9:30 am ET) Ronn Motor Company, announced that best-selling author and celebrity marketer, Dr. Joe Vitale, has purchased a Limited Edition Scorpion HX(TM).
Dr. Vitale stated, "I'm in the movie, 'The Secret,' but the real secret is a small company outside of Austin, Texas called Ronn Motor Company. They are making history with their breakthrough H2GO(TM) Real-Time Hydrogen Injection system and building a car that will turn heads and reduce the impact on the environment."
Dr. Vitale is the President of Hypnotic Marketing Inc., a marketing consulting firm based in Texas. He has been called "the Buddha of the Internet" for his combination of spirituality and marketing acumen. His best-selling book, "The Greatest Money Making Secret in History" and e-book "Hypnotic Writing" are a few of his outstanding literary achievements.
Ronn Maxwell, CEO of Ronn Motor Company, said, "We are honored to have the support of Dr. Vitale, a man who is respected for his creative thinking and innovative outlook on life. His endorsement of our automobile and alternative fuel strategy supports our resolve for automotive excellence and technological development."
Dr. Vitale added, "I love cars and the Scorpion is the only automobile that combines race car performance and unique styling without sucking the life out of our planet and that's a good thing."
Ronn Motor Company builds the eco-exotic Scorpion and Limited Edition Scorpion HX(TM) and will sell its hydrogen system in the automotive aftermarket for all cars, light trucks and commercial vehicles. The H2GO(TM) system enhances fuel mileage and reduces emissions -- both of which are concerns of the American public.
NACEL Energy Corporation (OTCBB: NCEN - http://finance.yahoo.com/q?s=NCEN.OB ) (Fri, Nov 7, 2008, 6:30 am ET) NACEL Energy Corporation ("NACEL Energy"), a wind power company in business to generate clean, renewable energy for America, today confirmed it has signed a long term wind development rights agreement covering 2082 acres of land for its Blue Creek wind energy project in Texas -- an area approximately 25% larger than previously anticipated by the Company.
The larger land parcel secured for wind power development means NACEL Energy's Blue Creek project may have greater generating potential than first determined by the Company. NACEL Energy's analysis indicates that the construction of a series of 10 MW phases is optimal and that 30 MW or more of generating capacity at Blue Creek may be achievable at project build out.
NACEL Energy's Blue Creek project is located in Moore County, in the Texas Panhandle. According to the Texas State Energy Conservation Office (SECO), the Panhandle contains the State's "greatest expanse of high quality winds." SECO's research indicates that while Class 4 wind locations such as Blue Creek comprise just 4.38% of the land area of Texas, these lands, in their aggregate, could supply 100% of the State's (1995) electric power consumption. (Source: SECO website, "The Energy Report 2008" Chapter 11 (Wind Energy), Exhibit 11-9)
Collection of site specific wind data has commenced at Blue Creek with the installation of a 60 meter (200 ft.) NRG meteorological tower transmitting data to NACEL Energy, via an Iridium satellite uplink. While the data is collected additional important development milestones including, without limitation, interconnection engineering, turbine engineering and obtaining turbine debt financing, must be completed by NACEL Energy. Accordingly, the Company cautions that project completion at Blue Creek is not expected until at least 2010.
NACEL Energy Chief Executive Officer, Brian Lavery, stated: "Securing 2082 acres for NACEL Energy's Blue Creek project in a long term development agreement, and the collection of site specific wind data which will enable future project engineering, are important milestones in the Company's pursuit of our corporate objective of 1000MW of wind power under development by 2010."
About OTCStockExchange.com
OTCStockExchange.com (OTCS) is a leading investor relations firm whose primary focus is promoting awareness among brokers, investors, and others in the investment community who are interested in small and micro-cap companies. OTCS is dedicated to helping publicly traded companies gain the exposure they need to move forward with the development of their business plans. OTCS's goal is to feature equity investments in micro or small capitalization companies that have the potential for long-term appreciation. OTCS provides all investors with the latest news, press releases, investment opinions, and research reports for all the companies highlighted on the site. OTCS offers a free financial newsletter. To subscribe or get more information, visit our home page located at http://www.otcstockexchange.com .
We offer many investor relations programs to public companies. To feature a company on our web site or in our daily Newsletter or Mid-Day Stock Alert, please contact Chris Wheeler at 585-330-8514 , or via email at info@otcstockexchange.com .
OTCS's affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event of a rise in value. Affiliates of the publisher for OTCS are to receive a fee of 500,000 shares of OpenCell BioMed Inc. (OTCBB: OCBM | Quote | Chart | News | PowerRating) from a third party for this investment opinion feature. OTCS will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
OTCStockExchange.com (OTCS) based upon information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by OTCS to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. OTCS is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.otcstockexchange.com or mentioned herein. OTCS has been compensated by third party shareholders or with cash from the company on behalf of one or more of the companies mentioned in this opinion.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and OTCS undertakes no obligation to update such statements.
CONTACT: Chris Wheeler, OTCStockExchange.com Tel: +1 585 330 8514 e-mail: info@otcstockexchange.com WWW: http://www.otcstockexchange.com
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
